Other
Sitagliptin And Metformin Hydrochloride Tablet, Film Coated, Extended Release
FDA Label NDC 70771-1887
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Sitagliptin And Metformin Hydrochloride (NDC 70771-1887). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding other, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Package Label.Principal Display Panel
NDC 70771-1886-6
Sitagliptin and metformin hydrochloride extended-release tablets for oral use
50 mg/500 mg
60 Tablets
Rx only
Label (586136d7 1c08 4507 A8fc 946d5cbefebb 01)
NDC 70771-1887-6
Sitagliptin and metformin hydrochloride extended-release tablets for oral use
50 mg/1000 mg
60 Tablets
Rx only
Label (586136d7 1c08 4507 A8fc 946d5cbefebb 02)
NDC 70771-1888-3
Sitagliptin and metformin hydrochloride extended-release tablets for oral use
100 mg/1000 mg
30 Tablets
Rx only
Label (586136d7 1c08 4507 A8fc 946d5cbefebb 03)
* Please review the disclaimer below.
